| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GNMK | GenMark Diagnostics, Inc. | Shaw Christine | VP, Assay Development | Apr 22, 2021 | Option Exercise | $24.05 | 101,324 | 2,436,842 | 0 | Apr 22, 2021, 01:53 PM | |
| GNMK | GenMark Diagnostics, Inc. | Shaw Christine | VP, Assay Development | Mar 05, 2021 | Sale | $18.56 | 274 | 5,085 | 102,196 | Mar 08, 2021, 05:32 PM | |
| GNMK | GenMark Diagnostics, Inc. | Shaw Christine | VP, Assay Development | Feb 26, 2021 | Sale | $17.03 | 3,151 | 53,662 | 102,470 | Mar 01, 2021, 05:48 PM | |
| GNMK | GenMark Diagnostics, Inc. | Shaw Christine | VP, Assay Development | Feb 24, 2021 | Sale | $19.12 | 259 | 4,952 | 105,621 | Feb 25, 2021, 06:32 PM | |
| GNMK | GenMark Diagnostics, Inc. | Shaw Christine | VP, Assay Development | Feb 23, 2021 | Sale | $19.35 | 166 | 3,212 | 105,880 | Feb 25, 2021, 06:32 PM | |
| GNMK | GenMark Diagnostics, Inc. | Shaw Christine | VP, Assay Development | Jan 27, 2021 | Sale | $14.06 | 81 | 1,139 | 79,796 | Jan 29, 2021, 05:15 PM | |
| GNMK | GenMark Diagnostics, Inc. | Shaw Christine | VP, Assay Development | Dec 07, 2020 | Sale | $13.97 | 274 | 3,828 | 79,877 | Dec 09, 2020, 05:24 PM | |
| GNMK | GenMark Diagnostics, Inc. | Shaw Christine | VP, Assay Development | Nov 24, 2020 | Sale | $13.17 | 355 | 4,675 | 79,291 | Nov 25, 2020, 05:29 PM | |
| GNMK | GenMark Diagnostics, Inc. | Shaw Christine | VP, Assay Development | Oct 27, 2020 | Sale | $11.34 | 68 | 771 | 79,646 | Oct 29, 2020, 06:09 PM | |
| GNMK | GenMark Diagnostics, Inc. | Shaw Christine | VP, Assay Development | Sep 08, 2020 | Sale | $11.02 | 285 | 3,141 | 79,714 | Sep 10, 2020, 06:14 PM | |
| GNMK | GenMark Diagnostics, Inc. | Shaw Christine | VP, Assay Development | Aug 25, 2020 | Sale | $14.14 | 379 | 5,359 | 79,999 | Aug 26, 2020, 06:17 PM |
Menu